Claraphi Advisory Network’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,489
| Closed | -$889K | – | 312 |
|
|
2021
Q2 | $889K | Sell |
5,489
-3,187
| -37% | -$516K | 0.27% | 77 |
|
|
2021
Q1 | $1.06M | Sell |
8,676
-2,201
| -20% | -$268K | 0.29% | 72 |
|
|
2020
Q4 | $1.67M | Buy |
10,877
+4,440
| +69% | +$680K | 0.45% | 34 |
|
|
2020
Q3 | $538K | Buy |
6,437
+2,381
| +59% | +$199K | 0.19% | 101 |
|
|
2020
Q2 | $298K | Buy |
+4,056
| New | +$298K | 0.13% | 161 |
|